SENNA- sennosides liquid 
PAI Holdings, LLC

----------

Senna

Active ingredient (per teaspoonful - 5 mL)

Sennosides - 8.8 mg

Purpose

Laxative

Uses

Warnings

Do not use

Ask a doctor or pharmacist before use if you have

Stop use and ask a doctor if

you have rectal bleeding or failure to have a bowel movemebt after use of laxative. They may indicate a serious condition.

If pregnant or breast-feeding ask a health professional before use.

Keep out of reach of children. In case of accidental overdose, get medical help or contact a Poison Control Center (1-800-222-1222) immediately.

AgeStarting Dose Maximum dosage
 Adults and children 12 years and older 2-3 teaspoonfuls once a day preferably at bedtime; increase as needed or as recommended by a doctor3 teaspoons in the morning and 3 teaspoons at bedtime
Under 12 years of age ask a doctor ask a doctor

Other information

NDC 0121-4967-05: 5 mL unit dose cup, in a tray of ten cups.
NDC 0121-4967-40: Case contains 40 unit dose cups of 5 mL (0121-4967-05) packaged in 4 trays of 10 unit dose cups each.

Inactive ingredients: citric acid, glycerin, methylparaben, potassium sorbate, propylparaben, purified water, and sucrose.

Questions or comments? 1-800-845-8210

Distributed By:

Pharmaceutical Associates, Inc.

Greenville, SC 29605

Delivers 5 mL
NDC 0121-4967-05

Senna Syrup

8.8 mg Sennosides/5 mL

Natural Vegetable Laxative

Package Not Child-Resistant

Pharmacutical Associates, Inc.
Greenville, SC 29605

SEE DRUG FACTS

image description
SENNA 
sennosides liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0121-4967
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.8 mg  in 5 mL
Inactive Ingredients
Ingredient NameStrength
CITRIC ACID ACETATE (UNII: DSO12WL7AU)  
GLYCERIN (UNII: PDC6A3C0OX)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
WATER (UNII: 059QF0KO0R)  
SUCROSE (UNII: C151H8M554)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0121-4967-404 in 1 CASE03/22/2022
110 in 1 TRAY
1NDC:0121-4967-055 mL in 1 CUP, UNIT-DOSE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph Drug505G(a)(3)03/22/2022
Labeler - PAI Holdings, LLC (044940096)
Establishment
NameAddressID/FEIBusiness Operations
PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma097630693label(0121-4967) , manufacture(0121-4967)

Revised: 1/2024
Document Id: 6dc5388e-c13d-4e64-816e-9ccf470b7a4c
Set id: 7c28ffb8-149f-4a5a-ab98-dfa7b3b0f6ed
Version: 6
Effective Time: 20240105
 
PAI Holdings, LLC